| Serotonin Transporters in Alcoholism (NCT00085865) | National Institute of Mental Health (NIMH) | 2004-06-01 |
| Treatment With Mecamylamine in Smoking and Non-smoking Alcohol Dependent Patients (NCT00342563) | Yale University | 2004-05-01 |
| Prazosin for ETOH or Cocaine Craving (NCT00240227) | US Department of Veterans Affairs | 2004-04-01 |
| Study of Aripiprazole in Subjects With Alcoholism (NCT00082199) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2004-04-01 |
| Clinical Trial Studying the Effects of Spironolactone on Heart and Skeletal Muscle Function in Chronic Alcoholics (NCT00226109) | University of Aarhus | 2004-04-01 |
| An Efficacy and Safety Study of Topiramate in the Treatment of Alcohol Dependence (NCT00210925) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2004-03-01 |
| Levetiracetam for the Treatment of Alcohol Dependence and Anxiety (NCT00141115) | New York State Psychiatric Institute | 2004-03-01 |
| Chicago Social Drinking Project (NCT00961792) | University of Chicago | 2004-03-01 |
| Sertraline Pharmacotherapy for Alcoholism Subtypes (NCT00368550) | UConn Health | 2004-02-01 |
| Gabapentin Treatment of Alcohol Dependence (NCT00391716) | The Scripps Research Institute | 2004-02-01 |
| Study To Examine Effect Of CP-866,087 On Consumption And Craving Of Alcohol In Alcohol Dependent Subjects. (NCT00147576) | Pfizer | 2003-12-01 |
| Health Behavior Feedback Study for Veterans With Hepatitis C (NCT00229580) | University of Washington | 2003-12-01 |
| ALK21-010: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol-dependent Adults (NCT00156923) | Alkermes, Inc. | 2003-10-01 |
| Alcohol and Gender Effects on Stress Circuit Function (NCT00226694) | University of Cincinnati | 2003-09-01 |
| The Effects of Topiramate on Alcohol Use in Alcohol Dependent Subjects (NCT00329407) | Boston University | 2003-09-01 |
| Managing Alcoholism in People Who Do Not Respond to Naltrexone (NCT00115037) | University of Pennsylvania | 2003-09-01 |
| ALK21-006: Long-Term Study of Medisorb® Naltrexone (VIVITROL®) (NCT01218997) | Alkermes, Inc. | 2003-08-01 |
| Outpatient Treatment of Alcohol Withdrawal Syndrome (NCT00136617) | Hvidovre University Hospital | 2003-08-01 |
| Trial for the Treatment of Alcohol Dependence (NCT00120601) | University of Sydney | 2003-03-01 |
| Quetiapine Fumarate (Seroquel) for the Treatment of Alcohol Dependence. (NCT00124059) | University of Pennsylvania | 2003-03-01 |
| Drug Therapy for Alcohol Dependence in Alaska Natives (Naltrexone/Sertraline) (NCT00000451) | Yale University | 2003-01-01 |
| Individually Adapted Therapy of Alcoholism (NCT00317031) | Central Institute of Mental Health, Mannheim | 2002-11-01 |
| Outpatient Versus Inpatient Detoxification Program for Alcohol Dependent Patients Seeking Abstinence: The IN/OUT Study (NCT00226720) | Assistance Publique - Hôpitaux de Paris | 2002-09-01 |
| Combination Nicotine Replacement for Alcoholic Smokers (NCT00064844) | Yale University | 2002-08-01 |
| Clinical-Genetic Variation in GABA/Alcohol Sensitivity (NCT00223444) | The University of Texas Health Science Center at San Antonio | 2002-08-01 |
| Trazodone for Sleep Disturbance in Early Alcohol Recovery (NCT00027053) | Rhode Island Hospital | 2002-06-01 |
| Bupropion as a Smoking Cessation Aid in Alcoholics (NCT00044434) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2002-05-01 |
| ALK21-003: Study of Medisorb® Naltrexone (VIVITROL®) in Alcohol-Dependent Adults (NCT01218958) | Alkermes, Inc. | 2002-02-01 |
| Effectiveness of Sertraline in Treating Pathological Gamblers With a Diagnosis of Alcohol Dependence - 1 (NCT00249431) | New York State Psychiatric Institute | 2001-12-01 |
| Naltrexone & SSRI in Alcoholics With Depression/PTSD (NCT00338962) | Yale University | 2001-10-01 |
| Combined Pharmacotherapies for Alcoholism (Naltrexone/Ondansetron) (NCT00027079) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2001-09-01 |
| Alcoholism: Emotion and Thinking (NCT00300638) | Boston University | 2001-08-01 |
| Pharmacological Intervention Project (Fluoxetine) (NCT00027378) | University of Pittsburgh | 2001-07-01 |
| Healthy Moms Alcohol Intervention (NCT00244062) | University of Wisconsin, Madison | 2001-04-01 |
| Ketamine/Placebo Family History Positive Study (NCT00588952) | Yale University | 2001-03-01 |
| Serotonin in Alcoholism (NCT00011752) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2001-02-01 |
| Treatment for Alcoholism and Post-Traumatic Stress Disorder (Naltrexone) (NCT00006489) | University of Pennsylvania | 2000-12-01 |
| Drug Treatment for Alcoholics With Bipolar Disorder (NCT00000439) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2000-10-01 |
| Post-Treatment Effects of Naltrexone (NCT00006449) | Indiana University | 2000-09-01 |
| Drug Treatment for Depressed Alcoholics (Naltrexone/Fluoxetine) (NCT00006204) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2000-03-01 |
| Sertraline for Alcohol Dependence and Depression (NCT00004554) | University of Pennsylvania | 2000-01-01 |
| Treating Alcohol Use In Older Adults With Depression (NCT00018824) | US Department of Veterans Affairs | 1999-10-01 |
| Group Therapies for Reducing HIV-risk Behavior in Women Who Have Survived Childhood Sexual Abuse (NCT00220597) | Stanford University | 1999-09-01 |
| Combination of Disulfiram Plus Naltrexone to Treat Both Cocaine- and Alcohol-dependent Individuals - 1 (NCT00142844) | University of Pennsylvania | 1999-09-01 |
| Behavioral Counseling for Alcohol Dependent Smokers (Nicotine Patch) (NCT00004551) | Mayo Clinic | 1999-02-01 |
| Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (Naltrexone/Nicotine Patch) (NCT00000447) | The University of Texas Health Science Center, Houston | 1998-09-01 |
| Pharmacologic Relapse Prevention for Alcoholic Smokers (NCT00000457) | Mayo Clinic | 1998-06-01 |
| Naltrexone in Two Models of Psychosocial Treatments for Cocaine and Alcohol Dependence - 1 (NCT00218660) | University of Pennsylvania | 1998-04-01 |
| The Effect of Positive and Negative Emotions on Brain Activity in Alcoholics and Nonalcoholics (NCT00001675) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 1998-01-23 |
| Naltrexone in Two Models of Psychosocial Treatments for Cocaine and Alcohol Dependence (NCT00167232) | University of Pennsylvania | 1998-01-01 |
| Screening Evaluation for Studies of the National Institute on Alcohol Abuse and Alcoholism (NIAAA) (NCT00001673) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 1997-10-02 |
| Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone) (NCT00000437) | The Scripps Research Institute | 1997-09-26 |
| Timing of Smoking Intervention in Alcohol Treatment (Nicotine Patch) (NCT00000444) | Minneapolis Veterans Affairs Medical Center | 1997-09-01 |
| COMBINE (Acamprosate/Naltrexone) (NCT00006206) | University of North Carolina, Chapel Hill | 1997-08-01 |
| Naltrexone Maintenance Treatment of Alcoholism (NCT00000450) | The Scripps Research Institute | 1997-04-10 |
| Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex Traits (NCT00001500) | National Cancer Institute (NCI) | 1996-04-01 |
| Naltrexone Treatment for Alcoholic Women (NCT00000448) | Yale University | 1995-10-01 |
| Behavioral Therapy Plus Naltrexone for Alcoholism (NCT00000456) | Medical University of South Carolina | 1992-09-01 |
| Genetic Factors and Interrelationships for Sexual Orientation, Susceptibility to HIV and Kaposi's Sarcoma, Alcoholism and Psychological Traits, and Histocompatibility Antigens (NCT00001294) | National Cancer Institute (NCI) | 1992-01-01 |
| Drug Treatment for Alcoholics With Post-Traumatic Stress Disorder (NCT00000446) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | |
| Naltrexone, Craving, and Drinking (NCT00006203) | Brown University | |
| Sertraline and Naltrexone for Alcohol Dependence (NCT00000440) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | |
| Naltrexone for Early Problem Drinkers (NCT00000455) | UConn Health | |
| Use of Naltrexone in a Clinical Setting (NCT00000445) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | |
| Sertraline and Cognitive Therapy in Depressed Alcoholics (NCT00000458) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | |
| Naltrexone for Relapse Prevention (NCT00000442) | UConn Health | |
| Drug Therapy for Alcohol Detoxification (NCT00000441) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | |
| Comparing Gabapentin and Lorazepam for Treating Alcohol Withdrawal (NCT00011297) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | |
| Behavior and Naltrexone Treatment for Alcoholics (NCT00000449) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | |
| Naltrexone Treatment for Alcoholism (NCT00000438) | Johns Hopkins University | |
| Smoking Cessation in Alcoholism Treatment (NCT00000454) | Yale University | |
| Naltrexone Treatment of Alcohol Dependence (NCT00000452) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | |
| Ondansetron Treatment for Alcoholism (NCT00000443) | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | |
| Preliminary Human Trial of NPI-028 (NCT00010907) | National Center for Complementary and Integrative Health (NCCIH) | |